United Therapeutics reported $308.7M in Pre-Tax Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Amarin AMRN:US $ -28.35M 44.74M
Ardelyx ARDX:US $ -28.07M 8.16M
Baxter International BAX:US $ 492M 157M
Biocryst Pharmaceuticals BCRX:US $ -73.92M 58.39M
Biogen BIIB:US $ 903.4M 316.6M
Biomarin Pharmaceutical BMRN:US $ 26.19M 92.76M
Esperion Therapeutics ESPR:US $ -56731000 8.39M
Halozyme Therapeutics HALO:US $ 81.63M 20.43M
Insmed INSM:US $ -94236000 18.78M
Intercept Pharmaceuticals ICPT:US $ -17.28M 19M
Intra Cellular Therapies ITCI:US $ -72.11M 13.62M
IONIS PHARMACEUT IONS:US $ -64M 289M
Johnson & Johnson JNJ:US $ 8218M 1879M
Lexicon Pharmaceuticals LXRX:US $ -23476000 2.13M
Moderna Inc MRNA:US 4.23B 1.18B
Omeros OMER:US $ -39494000 7.82M
Pfizer PFE:US $ 11328M 4083M
Ptc Therapeutics PTCT:US $ -121.89M 16.72M
Regeneron Pharmaceuticals REGN:US $ 1119.1M 1986M
Sangamo Biosciences SGMO:US $ -43.92M 6.36M
Sarepta Therapeutics SRPT:US $ -104.15M 17.74M
Seattle Genetics SGEN:US $ -135.24M 41.73M
Teva Pharmaceutical TEVA:IT -971000000 796M
United Therapeutics UTHR:US $ 308.7M 168.2M